Advertisement
Singapore markets open in 7 hours 58 minutes
  • Straits Times Index

    3,307.90
    -6.15 (-0.19%)
     
  • S&P 500

    5,319.75
    -1.66 (-0.03%)
     
  • Dow

    39,844.49
    -28.50 (-0.07%)
     
  • Nasdaq

    16,823.89
    -8.74 (-0.05%)
     
  • Bitcoin USD

    70,222.12
    +582.30 (+0.84%)
     
  • CMC Crypto 200

    1,522.56
    -3.86 (-0.25%)
     
  • FTSE 100

    8,370.33
    -46.12 (-0.55%)
     
  • Gold

    2,395.80
    -30.10 (-1.24%)
     
  • Crude Oil

    78.24
    -0.42 (-0.53%)
     
  • 10-Yr Bond

    4.4240
    +0.0100 (+0.23%)
     
  • Nikkei

    38,617.10
    -329.83 (-0.85%)
     
  • Hang Seng

    19,195.60
    -25.02 (-0.13%)
     
  • FTSE Bursa Malaysia

    1,622.09
    -5.41 (-0.33%)
     
  • Jakarta Composite Index

    7,222.38
    +36.34 (+0.51%)
     
  • PSE Index

    6,607.22
    -26.44 (-0.40%)
     

Is Medical Facilities Corporation (TSE:DR) Worth CA$11.2 Based On Its Intrinsic Value?

Key Insights

  • The projected fair value for Medical Facilities is CA$8.80 based on Dividend Discount Model

  • Medical Facilities is estimated to be 27% overvalued based on current share price of CA$11.18

How far off is Medical Facilities Corporation (TSE:DR) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced by taking the expected future cash flows and discounting them to today's value. The Discounted Cash Flow (DCF) model is the tool we will apply to do this. Models like these may appear beyond the comprehension of a lay person, but they're fairly easy to follow.

We generally believe that a company's value is the present value of all of the cash it will generate in the future. However, a DCF is just one valuation metric among many, and it is not without flaws. For those who are keen learners of equity analysis, the Simply Wall St analysis model here may be something of interest to you.

ADVERTISEMENT

View our latest analysis for Medical Facilities

What's The Estimated Valuation?

We have to calculate the value of Medical Facilities slightly differently to other stocks because it is a healthcare company. Instead of using free cash flows, which are hard to estimate and often not reported by analysts in this industry, dividends per share (DPS) payments are used. This often underestimates the value of a stock, but it can still be good as a comparison to competitors. We use the Gordon Growth Model, which assumes dividend will grow into perpetuity at a rate that can be sustained. For a number of reasons a very conservative growth rate is used that cannot exceed that of a company's Gross Domestic Product (GDP). In this case we used the 5-year average of the 10-year government bond yield (2.0%). The expected dividend per share is then discounted to today's value at a cost of equity of 5.7%. Compared to the current share price of CA$11.2, the company appears slightly overvalued at the time of writing. The assumptions in any calculation have a big impact on the valuation, so it is better to view this as a rough estimate, not precise down to the last cent.

Value Per Share = Expected Dividend Per Share / (Discount Rate - Perpetual Growth Rate)

= US$0.2 / (5.7% – 2.0%)

= CA$8.8

dcf
dcf

The Assumptions

The calculation above is very dependent on two assumptions. The first is the discount rate and the other is the cash flows. Part of investing is coming up with your own evaluation of a company's future performance, so try the calculation yourself and check your own assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Medical Facilities as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 5.7%, which is based on a levered beta of 0.800. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.

SWOT Analysis for Medical Facilities

Strength

  • Debt is not viewed as a risk.

  • Dividends are covered by earnings and cash flows.

Weakness

  • Dividend is low compared to the top 25% of dividend payers in the Healthcare market.

Opportunity

  • Annual earnings are forecast to grow for the next 2 years.

  • Good value based on P/E ratio compared to estimated Fair P/E ratio.

Threat

  • No apparent threats visible for DR.

Looking Ahead:

Valuation is only one side of the coin in terms of building your investment thesis, and it shouldn't be the only metric you look at when researching a company. The DCF model is not a perfect stock valuation tool. Rather it should be seen as a guide to "what assumptions need to be true for this stock to be under/overvalued?" For instance, if the terminal value growth rate is adjusted slightly, it can dramatically alter the overall result. Can we work out why the company is trading at a premium to intrinsic value? For Medical Facilities, we've compiled three essential items you should assess:

  1. Risks: Case in point, we've spotted 1 warning sign for Medical Facilities you should be aware of.

  2. Future Earnings: How does DR's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.

  3. Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered!

PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the TSX every day. If you want to find the calculation for other stocks just search here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.